NEW YORK CITY, NY / ACCESS Newswire / April 2, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies ...
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief digital and technology officer ...
GlobalData on MSN7d
FDA approves GSK’s Blujepa for uncomplicated UTIsThe US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene antibiotic, Blujepa (gepotidacin), for ...
GlobalData on MSN8d
EMA to review GSK’s Nucala for COPD treatment expansionGSK’s application is underpinned by the positive outcomes from the Phase III MATINEE trial, which demonstrated a significant ...
A vaccination to prevent horribly painful shingles may offer an extra benefit: New research suggests it might lower the risk ...
World Wide Fund for Nature (WWF) and global biopharma giant GSK have launched a five-year initiative to conserve and restore ...
Join GSK and WWF's initiative to restore 300,000m³ water in the Sutlej River Basin and Indus Delta by 2030, aiding 100,000 people in water-stressed regions.
Pharmaceutical Technology on MSN1d
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSKAbrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have gone elsewhere without tax incentives approved by local officials last year.
Pharmaceutical Technology on MSN8d
GSK and UK researchers plan to study Shingrix and dementia risk reduction linkThe study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback